Using Managed Entry Agreements as an Effective Tool to Handle the Uncertainty in Health Technology Assessments
Although the access to innovative medicines is usually informed by health technology assessment reports, underlying uncertainties in HTA may delay such access. Managed Entry Agreements may provide a promising solution to handle such uncertainty through focusing on value for information. Notably, ma...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2022-07-01
|
Series: | Health Technology Assessment in Action |
Subjects: | |
Online Access: | https://htainaction.tums.ac.ir/index.php/hta/article/view/110 |
_version_ | 1818477551139422208 |
---|---|
author | Vatsal Chhaya Kapil Khambholja |
author_facet | Vatsal Chhaya Kapil Khambholja |
author_sort | Vatsal Chhaya |
collection | DOAJ |
description |
Although the access to innovative medicines is usually informed by health technology assessment reports, underlying uncertainties in HTA may delay such access. Managed Entry Agreements may provide a promising solution to handle such uncertainty through focusing on value for information. Notably, majority of MEA designs include volume-based pricing and not outcome-based pricing strategies – which is an optimal access pathway for rare disease drugs. This is attributed to transparency issues regarding MEA content. This article proposes a framework which may be helpful which considering MEA within the context of low-and-middle-income countries using an interdisciplinary approach. This included needs assessment, value framework, governance, and choice of outcomes.
|
first_indexed | 2024-12-10T09:39:05Z |
format | Article |
id | doaj.art-b1463666f42e41e8b38f499221fcd00c |
institution | Directory Open Access Journal |
issn | 2645-3835 |
language | English |
last_indexed | 2024-12-10T09:39:05Z |
publishDate | 2022-07-01 |
publisher | Tehran University of Medical Sciences |
record_format | Article |
series | Health Technology Assessment in Action |
spelling | doaj.art-b1463666f42e41e8b38f499221fcd00c2022-12-22T01:54:05ZengTehran University of Medical SciencesHealth Technology Assessment in Action2645-38352022-07-0154Using Managed Entry Agreements as an Effective Tool to Handle the Uncertainty in Health Technology AssessmentsVatsal Chhaya0Kapil Khambholja1Genpro Research Pvt. Ltd., Thiruvananthapuram, KL, IndiaGenpro Research Pvt. Ltd., Thiruvananthapuram, KL, India & Genpro Research Inc, Waltham, MA, USA Although the access to innovative medicines is usually informed by health technology assessment reports, underlying uncertainties in HTA may delay such access. Managed Entry Agreements may provide a promising solution to handle such uncertainty through focusing on value for information. Notably, majority of MEA designs include volume-based pricing and not outcome-based pricing strategies – which is an optimal access pathway for rare disease drugs. This is attributed to transparency issues regarding MEA content. This article proposes a framework which may be helpful which considering MEA within the context of low-and-middle-income countries using an interdisciplinary approach. This included needs assessment, value framework, governance, and choice of outcomes. https://htainaction.tums.ac.ir/index.php/hta/article/view/110Healthcare Service AccessibilitymedicinesHTAcost benefit analysisquality adjusted life years |
spellingShingle | Vatsal Chhaya Kapil Khambholja Using Managed Entry Agreements as an Effective Tool to Handle the Uncertainty in Health Technology Assessments Health Technology Assessment in Action Healthcare Service Accessibility medicines HTA cost benefit analysis quality adjusted life years |
title | Using Managed Entry Agreements as an Effective Tool to Handle the Uncertainty in Health Technology Assessments |
title_full | Using Managed Entry Agreements as an Effective Tool to Handle the Uncertainty in Health Technology Assessments |
title_fullStr | Using Managed Entry Agreements as an Effective Tool to Handle the Uncertainty in Health Technology Assessments |
title_full_unstemmed | Using Managed Entry Agreements as an Effective Tool to Handle the Uncertainty in Health Technology Assessments |
title_short | Using Managed Entry Agreements as an Effective Tool to Handle the Uncertainty in Health Technology Assessments |
title_sort | using managed entry agreements as an effective tool to handle the uncertainty in health technology assessments |
topic | Healthcare Service Accessibility medicines HTA cost benefit analysis quality adjusted life years |
url | https://htainaction.tums.ac.ir/index.php/hta/article/view/110 |
work_keys_str_mv | AT vatsalchhaya usingmanagedentryagreementsasaneffectivetooltohandletheuncertaintyinhealthtechnologyassessments AT kapilkhambholja usingmanagedentryagreementsasaneffectivetooltohandletheuncertaintyinhealthtechnologyassessments |